Hovan Ramps Up Market Neutral Fund Team

Feb 6 2008 | 8:44am ET

Hovan Capital Management, a San Francisco-based healthcare focused long/short fund, has hired Ajim Tamboli as a senior portfolio manager of the HCM Market Neutral Fund. Tamboli previously served as a senior small biotechnology analyst at Lehman Brothers in San Francisco.

In addition, Lisa Lee-Hwong, previously with SAC Capital Advisors, has joined the firm to support Tamboli as a portfolio manager focused on emerging science. Current HCM analyst Mikael van Loon will be promoted to the role of portfolio manager in charge of top-down quantitative portfolio risk management.

“Ajim’s experience and interaction with the management teams of portfolio companies coupled with Dr. Lee-Hwong’s scientific research experience will provide a strong positive environment in HCM’s public equity healthcare research department,” said Kurt Hovan, president and CIO of HCM.

“Mikael has mastered HCM’s short portfolio quantitative process and is ready to assume the role of portfolio manager in the fund.”

Hovan Capital Management was established in September 1998.


In Depth

Malik: The Science of Deal Sourcing 201

Aug 27 2015 | 5:35pm ET

Deal sourcing is understandably a hot topic among private equity firms because it...

Lifestyle

Rolling Art Advisors Marketing Collectible Car Fund As Uncorrelated Alternative

Aug 27 2015 | 6:47pm ET

A new fund is trying to provide investors with greater access to an emerging asset...

Guest Contributor

Agecroft Partners: Hedge Fund Industry Assets to increase $250B by Summer 2016

Aug 11 2015 | 11:29am ET

Assets will continue to flow into the hedge fund industry despite long-standing...

 

Editor's Note